415 related articles for article (PubMed ID: 12643708)
1. NMR structure of two novel polyethylene glycol conjugates of the human growth hormone-releasing factor, hGRF(1-29)-NH2.
Digilio G; Barbero L; Bracco C; Corpillo D; Esposito P; Piquet G; Traversa S; Aime S
J Am Chem Soc; 2003 Mar; 125(12):3458-70. PubMed ID: 12643708
[TBL] [Abstract][Full Text] [Related]
2. Pegylated peptides. IV. Enhanced biological activity of site-directed pegylated GRF analogs.
Felix AM; Lu YA; Campbell RM
Int J Pept Protein Res; 1995; 46(3-4):253-64. PubMed ID: 8537179
[TBL] [Abstract][Full Text] [Related]
3. Site-specific PEGylation for high-yield preparation of Lys(21)-amine PEGylated growth hormone-releasing factor (GRF) (1-29) using a GRF(1-29) derivative FMOC-protected at Tyr(1) and Lys(12).
Youn YS; Lee KC
Bioconjug Chem; 2007; 18(2):500-6. PubMed ID: 17243755
[TBL] [Abstract][Full Text] [Related]
4. Secondary structure of a human growth hormone-releasing factor fragment (Leu27-hGRF(15-32)NH2) in aqueous/SDS micelle environments.
Kloosterman DA; Scahill TA; Friedman AR
Pept Res; 1993; 6(4):211-8. PubMed ID: 8400617
[TBL] [Abstract][Full Text] [Related]
5. Solution structures of cyclic and dicyclic analogues of growth hormone releasing factor as determined by two-dimensional NMR and CD spectroscopies and constrained molecular dynamics.
Fry DC; Madison VS; Greeley DN; Felix AM; Heimer EP; Frohman L; Campbell RM; Mowles TF; Toome V; Wegrzynski BB
Biopolymers; 1992 Jun; 32(6):649-66. PubMed ID: 1643268
[TBL] [Abstract][Full Text] [Related]
6. Pegylated peptides. II. Solid-phase synthesis of amino-, carboxy- and side-chain pegylated peptides.
Lu YA; Felix AM
Int J Pept Protein Res; 1994 Feb; 43(2):127-38. PubMed ID: 8200730
[TBL] [Abstract][Full Text] [Related]
7. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
[TBL] [Abstract][Full Text] [Related]
8. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
[TBL] [Abstract][Full Text] [Related]
9. 1H NMR analysis and in vitro bioactivity of Leu27-bGRF(1-29)NH2 and its D-Ala2 and des-(Tyr1-Ala2)-analogs.
Kloosterman DA; Scahill TA; Hillman RM; Cleary DL; Kubiak TM
Pept Res; 1991; 4(2):72-8. PubMed ID: 1667740
[TBL] [Abstract][Full Text] [Related]
10. Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies.
Cervini LA; Donaldson CJ; Koerber SC; Vale WW; Rivier JE
J Med Chem; 1998 Feb; 41(5):717-27. PubMed ID: 9513600
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and conformational features of human salivary mucin C-terminal derived peptide epitope carrying Thomsen-Friedenreich antigen: implications for its role in self-association.
Satyanarayana J; Gururaja TL; Narasimhamurthy S; Naganagowda GA; Levine MJ
Biopolymers; 2001 Apr; 58(5):500-10. PubMed ID: 11241221
[TBL] [Abstract][Full Text] [Related]
12. Aggregation properties of the peptide fragments derived from the 17-29 region of the human and rat IAPP: a comparative study with two PEG-conjugated variants of the human sequence.
Mazzaglia A; Micali N; Scolaro LM; Attanasio F; Magrà A; Pappalardo G; Villari V
J Phys Chem B; 2010 Jan; 114(2):705-13. PubMed ID: 20039665
[TBL] [Abstract][Full Text] [Related]
13. Conformational analysis of the type II and type III collagen alpha-1 chain N-telopeptides by 1H-NMR spectroscopy and restrained molecular mechanics calculations.
Otter A; Scott PG; Kotovych G
Biopolymers; 1993 Sep; 33(9):1443-59. PubMed ID: 8400034
[TBL] [Abstract][Full Text] [Related]
14. Mono- and bicyclic analogs of parathyroid hormone-related protein. 2. Conformational analysis of antagonists by CD, NMR, and distance geometry calculations.
Maretto S; Mammi S; Bissacco E; Peggion E; Bisello A; Rosenblatt M; Chorev M; Mierke DF
Biochemistry; 1997 Mar; 36(11):3300-7. PubMed ID: 9116008
[TBL] [Abstract][Full Text] [Related]
15. Conformational origin of a difficult coupling in a human growth hormone releasing factor analog.
Deber CM; Lutek MK; Heimer EP; Felix AM
Pept Res; 1989; 2(2):184-8. PubMed ID: 2520756
[TBL] [Abstract][Full Text] [Related]
16. Toward parathyroid hormone minimization: conformational studies of cyclic PTH(1-14) analogues.
Tsomaia N; Pellegrini M; Hyde K; Gardella TJ; Mierke DF
Biochemistry; 2004 Jan; 43(3):690-9. PubMed ID: 14730973
[TBL] [Abstract][Full Text] [Related]
17. Site-specific PEGylation of bone morphogenetic protein-2 cysteine analogues.
Hu J; Duppatla V; Harth S; Schmitz W; Sebald W
Bioconjug Chem; 2010 Oct; 21(10):1762-72. PubMed ID: 20886828
[TBL] [Abstract][Full Text] [Related]
18. Conformational preferences of a short Aib/Ala-based water-soluble peptide as a function of temperature.
Banerjee R; Chattopadhyay S; Basu G
Proteins; 2009 Jul; 76(1):184-200. PubMed ID: 19137603
[TBL] [Abstract][Full Text] [Related]
19. Pegylated peptides. V. Carboxy-terminal PEGylated analogs of growth hormone-releasing factor (GRF) display enhanced duration of biological activity in vivo.
Campbell RM; Heimer EP; Ahmad M; Eisenbeis HG; Lambros TJ; Lee Y; Miller RW; Stricker PR; Felix AM
J Pept Res; 1997 Jun; 49(6):527-37. PubMed ID: 9266480
[TBL] [Abstract][Full Text] [Related]
20. Optimal site-specific PEGylation of mutant TNF-alpha improves its antitumor potency.
Yoshioka Y; Tsutsumi Y; Ikemizu S; Yamamoto Y; Shibata H; Nishibata T; Mukai Y; Okamoto T; Taniai M; Kawamura M; Abe Y; Nakagawa S; Nagata S; Yamagata Y; Mayumi T
Biochem Biophys Res Commun; 2004 Mar; 315(4):808-14. PubMed ID: 14985084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
